Lancet Series Addresses Tuberculosis Diagnosis, Treatment, Drug Resistance

The Lancet: Tuberculosis 2019
“Tuberculosis remains the leading cause of death from an infectious disease worldwide. With the targets of the WHO End TB Strategy set, the need for effective prevention and treatment is even more urgent. … In this Series, we present how diagnosis of multidrug-resistant tuberculosis can be improved, how drug regimens could be used to best treat different patient populations, and future perspectives for management of multidrug-resistant tuberculosis…” (9/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.